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A b s t r a c t  
Two simple, rapid, accurate and precise spectrophotometric methods have been developed for 
simultaneous estimation of Nimorazole and Ofloxacin from tablet dosage form. Method І involves 
formation of ‘simultaneous equations’ at 304 nm (λ max of Nimorazole) and 287.5 nm (λ max of 
Ofloxacin); while Method ІІ involves, formation of ‘Absorbance ratio equation’ at 301 (isoabsorptive 
point) and 287.5 nm (λ max of Ofloxacin) using distilled water as a solvent. The linearity was 
observed in the concentration range of 5- 25 μg/ml for Nimorazole and 2-10 μg/ml for Ofloxacin. The 
results of analysis have been validated statistically and by recovery studies and were found 
satisfactory.   
Kewords: Ofloxacin, Nimorazole, Simultaneous equation method, Absorbance ratio method.
Introduction 
Ofloxacin (OFX) is a fluoroquinolone derivative with potent activity 
against a broad spectrum of bacteria. Chemically, it is (±)-9-fluoro-2, 
3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido-
[1,2,3-de]-1,4-benzoxazine -6-carboxylic acid1 (Figure 1). It is 
mainly used as antibacterial for the treatment of urinary tract 
infection and sexually transmitted diseases [1]. 
 
Figure.1 Structure of OFX 
 
 Nimorazole (NIM) is a 5-nitroimidazole, which is closely related to 
Metronidazole in structure and activity. Nimorazole is used as a 
hypoxic sensitizer concomitantly with radiotherapy for head and 
neck cancers and could from the similarities with Metronidazole 
theoretically lead to increased effect of anticoagulant therapy. 
Nimorazole chemically known as 4-[2-(5-nitro-1H-imidazole-1-
yl)ethyl] morpholine 2 (Figure. 2) [2]. 
 
 
Figure 2 structure of NIM 
 
Literature survey assured that very few analytical methods such as 
HPLC [3-6], UV [7-12] were reported for the estimation of OFX and 
NIM either individually or combined with other drugs. only two 
methods are reported for estimation of Ofloxacin and Nimorazole in 
combination by RP-HPLC [13] and Vierordt’s [14] method So here 
an attempt has been made to develop simple, accurate, sensitive, 
rapid and economic method for simultaneous estimation of 
Ofloxacin and Nimorazole from tablet dosage forms using Vierordt’s 
method and Absorbance ratio method. 
 




Shimadzu 1601 UV-VIS double beam spectrophotometer with UV 
probe software was used. Absorbance Absorbance of 
measurements were recorded with a pair of 1cm matched quartz 
cells. 
 
Chemicals and Reagents   
                                                   
Working standards of NIM (99.68 %) and OFX (99.35%) were kindly 
supplied by Lupin Pvt. Ltd. (Jammu and Kashmir) and Zim 
Laboratory Ltd. (Nagpur). distilled water was used throughout the 
experiment. The pharmaceutical formulation used in this study was 
NIMORAZ O tablets (Lupin Ltd, Mumbai, India) procured from the 
local market and labelled to contain 200mg OFX and 500mg NIM 
per tablet. 
 
Preparation of standard stock solution 
 
10 mg of OFX and 25 mg NIM were weighed accurately and 
transferred in to a separate 50 volumetric flasks and sufficient 
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minutes. Finally the volume was adjusted up to the mark with 
water.5ml was pip petted out from each stock solution in to a 50ml 
volumetric flask and the volume was adjusted to 50mL with water, 
and again pipetted out 5ml from OFX stock solution and 2ml from 
NIM stock solution in 10 volumetric flasks so as to get the final 




Method I: Simultaneous Equation Method 
 
In simultaneous equation method,   when no region can be found 
free from overlapping spectra of two chromophore 
it is still possible to device a method based on measurements at 
two wavelengths. 
Two dissimilar chromophores must necessary have different 
powers of light absorption at some point or in linear absorption 
spectra.  
If samples contain two absorbing drugs (X and Y), each of which 
absorbs at the λmax of the other, it may be possible to determine 
both drugs by the technique of simultaneous equations 
From overlain spectra (Figure.1) 287.5nm λmax for Ofloxacin and 
301 nm λmax for Nimorazole were selected for formation of 
simultaneous equation of two drugs. 
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Where, A1 and A2 were absorbance of sample at 287.5 nm and 
301 nm respectively, ax1 and ax2 are absorptivity of Ofloxacin at 
287.5 nm and 301nm, ay1 and ay2 are absorptivity of Nimorazole 
at 287.5 nm and 30 nm. 
Validity of above framed equation was checked by using mixed 
standard of pure drug sample of two drugs, measuring their 
absorbance at respective wavelength and calculating concentration 
of two components. Results of which are reported in Table.1. 
 
Method II: Absorbance Ratio Method 
 
The absorbance ratio method is a modification of the simultaneous 
equation procedure. It depends on the property that, for a 
substance which obeys Beer’s Law at all wavelengths is a constant 
value independent of concentration or Path length. 
In the quantitative assay of two components in admixture by the 
absorbance by the absorbance ratio method, absorbance’s are 
measured at two wavelengths one being the λmax of one of the 
components (λ2) and the other being a wavelength of equal 
absorptivity of the two components (λ1), that is , an isoabsorptive 
point. 
From overlain spectra (Figure 1.) 301 nm (Isobestic point) and 
287.5 nm λmax for Ofloxacin were selected for formation of 
Absorbance ratio equation of two drugs. 
The absorbance at 301 nm and 287.5 nm for NIM and   OFL were 
measured. The absorptivity values of each drug at both 
wavelengths were determined. The absorbance and absorptivity at 
this wavelength were substituted in following equations to obtain 
the concentration of both drugs. 
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QM, QX, and QY were obtained as below:  
QM = A2/A1, QX = ax2/ax1, QY = ay2/ay1 
Where, A1 and A2 were absorbance of sample at 301 nm and 
287.5 nm respectively, ax1 and ax2 are absorptivity of Ofloxacin at 
301 nm and 287.5 nm, ay1 and ay2 are absorptivity of Nimorazole 
at 301 nm and 287.5 nm. 
Validity of above framed equation was checked by using mixed 
standard of pure drug sample of two drugs, measuring their 
absorbance at respective wavelength and calculating concentration 
of two components. Results of which are reported in Table.1 
 
Assay of tablet formulation 
 
Twenty tablets were weighed and crushed to obtain a fine powder. 
An accurately weighed sample equivalent to 200 mg of OFX and 
500mg of NIM was taken in a stoppered volumetric flask (100.0ml); 
40ml of water was added and sonicated for 20 min. The solution 
was filtered through Whatmann filter paper (No 41) and the volume 
was made up to the mark with the same solvent. The aliquot 
portions of above solutions were further diluted with solvent to get 
final concentration of about 200 mcg/ml of OFX and 500 mcg/ml of 
NIM, respectively and absorbances were measured at 287.5 nm, 
304 nm and 301.0 nm against blank. The concentrations of two 
drugs in sample were determined by using equations 1 and 2 and 
equation 3 and 4. The results are reported in the Table 2. 
 
Recovery studies  
 
The accuracy of the proposed method was checked by recovery 
studies, by addition of standard drug solution to pre analyzed 
sample solution at three different concentration levels (80%, 100%, 
and 120%) within range of linearity for both the drugs. Results are 
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Results and Conclusion 
Method I: Simultaneous Equation Method  
 
UV-spectrophotometric method using simultaneous equation was 
developed. OFX showed absorbance maxima at 287.5 nm and NIM 
at 304.0 nm. Linearity was observed in the concentration rage of 2 - 
10 μg/ml for OFX and 5 -25 μg/ml for NIM correlation coefficient 
was found to be 0.9996 and 0.9998 at 287.5 nm and 304 nm 
respectively. The proposed method was applied for pharmaceutical 
formulation and % label claim for OFX and NIM was found to be 
99.50 and 101.50, respectively. The method is accurate and precise 




Method II: Absorbance Ratio Method  
 
UV-spectrophotometric method by using absorbance ratio method 
was developed. Absorbances selected were 301 nm (isoabsorptive 
point) and 287.5 nm (λ max of Ofloxacin) Linearity was observed in 
the concentration range of 2 - 10 μg/ml and 5 - 25 μg/ml 
correlation coefficient was found to be 0.999 and 0.998 respectively 
The proposed method was applied for pharmaceutical formulation; 
% label claim for OFX and NIM was found to be 99.26 and 101.27, 
respectively. The low C.V. value indicates method is accurate and 
precise. 
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